A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment

F1000Research
Victoria McCreanorGregory Merlo

Abstract

Background: Cardiovascular disease remains the primary cause of death among Australians, despite dramatic improvements in overall cardiovascular health since the 1980s. Treating cardiovascular disease continues to place a significant economic strain on the Australian health care system, with direct healthcare costs exceeding those of any other disease. Coronary artery disease accounts for nearly one third of these costs and spending continues to rise. A range of treatments is available for coronary artery disease yet evidence of cost-effectiveness is missing, particularly for the Australian context. Cost-effectiveness evidence can signal waste and inefficiency and so is essential for an efficient allocation of healthcare resources. Methods: We used systematic review methods to search the literature across several electronic databases for economic evaluations of treatments for stable coronary artery disease.  We critically appraised the literature found in searches, both against the CHEERS statement for quality reporting of economic evaluations and in terms of its usefulness for policy and decision-makers. Results: We retrieved a total of 308 references, 229 once duplicates were removed. Of these, 26 were excluded as they were n...Continue Reading

References

Sep 14, 2004·Health Technology Assessment : HTA·R HillT Walley
Feb 2, 2006·Scandinavian Cardiovascular Journal : SCJ·Mattias EkmanStefan James
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Apr 24, 2007·QJM : Monthly Journal of the Association of Physicians·D FidanS Capewell
Aug 16, 2008·The New England Journal of Medicine·William S WeintraubG B J Mancini
Jun 9, 2009·The New England Journal of Medicine·UNKNOWN BARI 2D Study GroupBurton E Sobel
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Nov 19, 2009·Circulation·Mark A HlatkyUNKNOWN Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group
Mar 29, 2012·The New England Journal of Medicine·William S WeintraubFred H Edwards
Mar 23, 2013·Clinical and Experimental Pharmacology & Physiology·Anne-Marie WatersLynelle Moon
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN CHEERS Task Force
Jan 5, 2014·BMC Health Services Research·Kathryn OliverJames Thomas
Nov 1, 2016·BMJ : British Medical Journal·Hans LundIain Chalmers

❮ Previous
Next ❯

Citations

Feb 7, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Inês Souto RibeiroCarlos Miguel Costa Alves
Jun 22, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Licheng GongHong Chang
Apr 27, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Safeer KhanIhsan Ullah

❮ Previous
Next ❯

Software Mentioned

ISCHEMIA
ORBITA
ProQuest
EndNote
Ebscohost
EconLit

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.